Product Description
MMR vaccine. The vaccine protects against three diseases: measles, mumps, and rubella. CDC recommends children get two doses of MMR vaccine, starting with the first dose at 12 through 15 months of age, and the second dose at 4 through 6 years of age.High Efficacy, Proven SafetyThe MMR Vaccine demonstrates a greater than 95% seroconversion rate, ensuring robust immunity against measles, mumps, and rubella. Its clinically proven effectiveness and safety profile make it suitable for both children and adults, supporting use in national and international immunization programs. Regulatory approvals from WHO and health authorities assure quality compliance for hospital use.
Convenient and Reliable PackagingPackaged in sterile glass vials with a clear diluent, this vaccine is portable and easy to handle in healthcare settings. Batch numbers and expiry dates are clearly marked for reliable traceability. Available in both single and multi-dose formats, the lyophilized vaccine remains stable and effective when stored between 2C and 8C, ensuring usability across a range of clinical environments.
FAQ's of MMR Vaccine:
Q: How is the MMR Vaccine administered?
A: The MMR Vaccine is given via a subcutaneous injection after reconstituting the lyophilized powder with the supplied diluent. Healthcare professionals perform the process using sterile techniques to ensure safety.
Q: What age groups can receive the MMR Vaccine?
A: This vaccine is suitable for children aged 9 months and above, as well as adults. Immunization schedules typically recommend one or two doses, depending on regional guidelines and individual needs.
Q: When should the MMR Vaccine not be used?
A: The MMR Vaccine is contraindicated for immunocompromised individuals and pregnant women due to risks associated with live attenuated viruses. Always consult a healthcare provider for suitability before administration.
Q: Where should the MMR Vaccine be stored?
A: It must be stored in a refrigerator between 2C and 8C. Freezing should be strictly avoided to maintain vaccine potency and efficacy throughout its 18-24 month shelf life.
Q: What is the process for preparing and using the MMR Vaccine?
A: Reconstitution is required before administration: the provided diluent is added to the lyophilized powder under sterile conditions. The vaccine is then injected subcutaneously, usually by trained hospital or clinical staff.
Q: What are the benefits of MMR immunization?
A: Immunization with the MMR Vaccine provides highly effective protection against measles, mumps, and rubella, reducing disease transmission and complications for individuals and entire communities.
Q: Can the vaccine be traced for safety and quality?
A: Yes, batch numbers and expiry dates are printed on every vial and outer carton, ensuring product traceability and compliance with regulatory standards maintained by national authorities and the WHO.